Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000785 | chromatin | 2 | 1 |
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HQK9
Term | Name | Level | Count |
---|---|---|---|
GO:0006325 | chromatin organization | 4 | 1 |
GO:0006338 | chromatin remodeling | 5 | 1 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003677 | DNA binding | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0005515 | protein binding | 2 | 1 |
GO:0042393 | histone binding | 3 | 1 |
GO:0070577 | lysine-acetylated histone binding | 4 | 1 |
GO:0140030 | modification-dependent protein binding | 3 | 1 |
GO:0140033 | acetylation-dependent protein binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.455 |
CLV_C14_Caspase3-7 | 43 | 47 | PF00656 | 0.262 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.563 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.191 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.318 |
CLV_PCSK_FUR_1 | 15 | 19 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.551 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 17 | 19 | PF00082 | 0.444 |
CLV_PCSK_PC7_1 | 13 | 19 | PF00082 | 0.425 |
CLV_PCSK_PC7_1 | 213 | 219 | PF00082 | 0.583 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.430 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.390 |
CLV_Separin_Metazoa | 153 | 157 | PF03568 | 0.469 |
DEG_SPOP_SBC_1 | 166 | 170 | PF00917 | 0.405 |
DOC_MAPK_MEF2A_6 | 112 | 121 | PF00069 | 0.439 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.307 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.477 |
DOC_USP7_MATH_1 | 209 | 213 | PF00917 | 0.377 |
DOC_WW_Pin1_4 | 261 | 266 | PF00397 | 0.571 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.486 |
LIG_14-3-3_CanoR_1 | 124 | 133 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 156 | 161 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 178 | 188 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 18 | 27 | PF00244 | 0.542 |
LIG_14-3-3_CanoR_1 | 53 | 59 | PF00244 | 0.454 |
LIG_Actin_WH2_2 | 114 | 132 | PF00022 | 0.491 |
LIG_BIR_III_2 | 241 | 245 | PF00653 | 0.489 |
LIG_BRCT_BRCA1_1 | 20 | 24 | PF00533 | 0.303 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.260 |
LIG_GBD_Chelix_1 | 8 | 16 | PF00786 | 0.476 |
LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 21 | 27 | PF02991 | 0.438 |
LIG_PTB_Apo_2 | 95 | 102 | PF02174 | 0.416 |
LIG_PTB_Phospho_1 | 95 | 101 | PF10480 | 0.416 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.421 |
LIG_SH2_SRC | 26 | 29 | PF00017 | 0.529 |
LIG_SH2_STAP1 | 61 | 65 | PF00017 | 0.340 |
LIG_SH2_STAP1 | 81 | 85 | PF00017 | 0.145 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.246 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.529 |
LIG_SH3_1 | 130 | 136 | PF00018 | 0.531 |
LIG_SH3_3 | 130 | 136 | PF00018 | 0.411 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.340 |
LIG_WRC_WIRS_1 | 157 | 162 | PF05994 | 0.247 |
MOD_CDC14_SPxK_1 | 264 | 267 | PF00782 | 0.685 |
MOD_CDK_SPxK_1 | 261 | 267 | PF00069 | 0.691 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.444 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.529 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.369 |
MOD_CK1_1 | 212 | 218 | PF00069 | 0.532 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.279 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.543 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.521 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.492 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.472 |
MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.456 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.523 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.410 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.425 |
MOD_N-GLC_2 | 98 | 100 | PF02516 | 0.425 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.402 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.581 |
MOD_PKA_1 | 18 | 24 | PF00069 | 0.292 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.292 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.562 |
MOD_PKA_2 | 212 | 218 | PF00069 | 0.354 |
MOD_Plk_2-3 | 40 | 46 | PF00069 | 0.365 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.492 |
MOD_ProDKin_1 | 261 | 267 | PF00069 | 0.571 |
MOD_SUMO_rev_2 | 194 | 203 | PF00179 | 0.560 |
TRG_DiLeu_BaEn_4 | 270 | 276 | PF01217 | 0.480 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.334 |
TRG_ER_diArg_1 | 12 | 15 | PF00400 | 0.465 |
TRG_ER_diArg_1 | 18 | 20 | PF00400 | 0.453 |
TRG_ER_diArg_1 | 185 | 187 | PF00400 | 0.357 |
TRG_ER_diArg_1 | 217 | 219 | PF00400 | 0.551 |
TRG_ER_diArg_1 | 36 | 38 | PF00400 | 0.145 |
TRG_NLS_MonoCore_2 | 16 | 21 | PF00514 | 0.462 |
TRG_NLS_MonoExtC_3 | 16 | 22 | PF00514 | 0.566 |
TRG_NLS_MonoExtN_4 | 15 | 21 | PF00514 | 0.558 |
TRG_Pf-PMV_PEXEL_1 | 36 | 40 | PF00026 | 0.413 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD97 | Leptomonas seymouri | 71% | 100% |
A0A0S4KI88 | Bodo saltans | 26% | 100% |
A0A1X0NN00 | Trypanosomatidae | 37% | 96% |
A0A3Q8IM77 | Leishmania donovani | 86% | 100% |
A0A422NVW8 | Trypanosoma rangeli | 35% | 97% |
A4ICC9 | Leishmania infantum | 86% | 100% |
D0A3R1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 95% |
E9AUC4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q066 | Leishmania major | 87% | 100% |
V5DDW0 | Trypanosoma cruzi | 33% | 97% |